US Oncology Business Development Manager Salaries in Fort Worth, TX
The average US Oncology Business Development Manager in Fort Worth, TX earns an estimated $130,204 annually, which includes an estimated base salary of $103,871 with a $26,333 bonus. US Oncology's Business Development Manager compensation is $1,936 less than the US average for a Business Development Manager. Business Development Manager salaries at US Oncology in Fort Worth, TX can range from $55,000 - $210,000.
In Fort Worth, TX, The Business Development Department at US Oncology earns $11,664 more on average than the Customer Support Department.
Last updated 7 months ago.
- $103,871
- avg. base
- $26,333
- avg. bonus
Business Development Manager Salaries at US Oncology
In Fort Worth, TX, Business Development Managers earn $3,620 more than Business Development Managers, and $76,391 less than Directors of Business Development.
Compensation at US Oncology by Department
In Fort Worth, TX, The Business Development Department averages $11,664 more than the Customer Support Department, and $493 less than the Sales Department
Business Development Manager Compensation by Gender (All Companies)
The average female Business Development Manager at companies similar size to US Oncology reported making $151,865, while the average male Business Development Manager at similar sized companies reported making $160,499.
Business Development Manager Compensation by Ethnicity (All Companies)
The average Hispanic or Latino Business Development Manager at companies similar size to US Oncology reported making $180,546, while the average African American/Black Business Development Manager at similar sized companies reported making $121,400.
How Business Development Managers at US Oncology Rate Their Compensation
The majority of Business Development Managers at US Oncology believe they're compensated fairly. 50% of Business Development Managers at US Oncology say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at US Oncology
